Stealth’s injection, known as elamipretide, will be sold as Forzinity for the treatment of Barth syndrome, an X-linked ...

Separately, the ACIP members reversed their vote on a recommendation they’d shot down Thursday pertaining to coverage of ...

While the test was conducted in NSCLC, the FDA approval includes existing solid tumor indications for Keytruda. Merck is ...

After reaching the summit in a yearslong mission of introducing Takeda’s plasma-derived therapies (PDTs) to the market in its ...